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Abstract
ELOVL4 was Wrst identiWed as a disease-causing gene in Stargardt macular dystrophy (STGD3, MIM 600110.) To date, three
ELOVL4 mutations have been identiWed, all of which result in truncated proteins which induce autosomal dominant juvenile macular
degenerations. Based on sequence homology, ELOVL4 is thought to be another member within a family of proteins functioning in the
elongation of long chain fatty acids. However, the normal function of ELOVL4 is unclear. We generated Elovl4 knockout mice to deter-
mine if Elovl4 loss aVects retinal development or function. Here we show that Elovl4 knockout mice, while perinatal lethal, exhibit normal
retinal development prior to death at day of birth. Further, postnatal retinal development in Elovl4 heterozygous mice appears normal.
Therefore haploinsuYciency for wildtype ELOVL4 in autosomal dominant macular degeneration likely does not contribute to juvenile
macular degeneration in STGD3 patients. We found, however, that Elovl4+/¡ mice exhibit enhanced ERG scotopic and photopic a and b
waves relative to wildtype Elovl4+/+ mice suggesting that reduced Elovl4 levels may impact retinal electrophysiological responses.
© 2006 Elsevier Ltd. All rights reserved.
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Stargardt macular dystrophy 3 (STGD3) is an autoso-
mal dominant juvenile retinal disease characterized by pro-
gressive accumulation of lipofuscin, atrophy of the retinal
pigment epithelium (RPE), and degeneration of macular
photoreceptors. Disease causing mutations have been iden-
tiWed in the elongation of very long chain fatty acid-4
(ELOVL4) gene. ELOVL4 is characterized by multiple
putative membrane-spanning domains, a histidine cluster
* Corresponding authors. Fax: +1 801 585 3501 (K. Zhang).
E-mail addresses: Kim.Howes@hsc.utah.edu (K. Howes), Kang.Zhang
@hmbg.utah.edu (K. Zhang).
1 These authors contributed equally to this work.0042-6989/$ - see front matter © 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2006.10.023motif (HXXHH) involved in enzymatic activity (Fox,
Shanklin, Ai, Loehr, & Sanders-Loehr, 1994; Shanklin,
Whittle, & Fox, 1994), and an ER retention signal (Leonard
et al., 2000). The ELO family members are thought to be a
part of a complex enzymatic system, which participate in
the catalysis of reduction reactions occurring during fatty
acid elongation (Cinti, Cook, Nagi, & Suneja, 1992; Tvrdik
et al., 2000).
Mutational analysis of the ELOVL4 gene in Wve large
STGD-like macular dystrophy pedigrees revealed a 5 base-
pair deletion, resulting in a frame-shift and the introduction
of a stop codon, 51 codons from the end of the coding
region (Zhang et al., 2001). Subsequently, we identiWed two
single base-pair deletions, 789delT and 794delT, in
ELOVL4 in an independent large Utah pedigree, conWrm-
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macular dystrophies (Bernstein et al., 2001). The Wve base-
pair deletion and the two single base-pair deletions are pre-
dicted to result in a similarly truncated ELOVL4 protein.
We next identiWed the Y270 stop mutation, which generates
a truncated ELOVL4 protein, in a Dutch family with domi-
nant STGD (Maugeri et al., 2004). The mutations, identi-
Wed to date, result in loss of the C-terminal dilysine motif
encoding the putative ER retention signal (KXKXX). We
and others have shown in cell transfection studies that these
mutations result in loss of ER retention, and when cotrans-
fected with wildtype ELOVL4, additionally alters localiza-
tion of the wild type protein into nonER perinuclear
aggregates (Grayson & Molday, 2005; Karan, Yang, et al.,
2005; Vasireddy et al., 2005). We also generated several
lines of 5bp ELOVL4 mutant transgenic mice. Correspond-
ing to expression levels, these mice recapitulate major fea-
tures of retinal pathogenesis in STGD3 patients showing
lipofuscin accumulation, ERG abnormalities, and RPE and
photoreceptor degeneration (Karan, Lillo, et al., 2005).
Based on these Wndings, it is currently believed that
ELOVL4 mutant proteins exert a dominant negative eVect
by sequestering and inhibiting wildtype ELOVL4 activity.
However, it remains unclear, in vivo, as to whether a domi-
nant negative eVect from the mutant protein is solely
responsible for degeneration or whether haploinsuYciency
may contribute to retinal pathogenesis. To examine this
mechanism, we generated Elovl4 knockout mice for func-
tional consequences of Elovl4 loss in retinal developmentand early onset retinal degeneration. Here, we show that
Elovl4¡/¡ mice, while perinatal lethal, exhibit normal retinal
development up to time of death at P0. Further, Elovl4 het-
erozygous mice do not exhibit retinal degeneration up to 11
months of age. The Elovl4+/¡ mice do, however, show
enhanced ERG responses indicating that single gene
expression may aVect, to some extent, fully normal retinal
function. These results further support in an animal model,
that a dominant negative eVect, rather than haploinsuY-
ciency, is the primary mechanism of juvenile retinal degen-
eration in STGD3 patients.
2. Methods
2.1. Generation of Elovl4 KO mice
All animals were housed and handled in accordance with procedures
provided by the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research. Elolv4 knockout mice were generated using a gene
targeting approach. An arrayed 129/Sv BAC genomic library (Stratagene),
was used to identify, by PCR, two BAC clones, 5E1 and 23D19, containing
the mouse Elovl4 gene. By sequencing, we conWrmed that the clone 5E1
contains Elovl4 and subsequently used the Not1 fragment for subcloning.
By standard recombinant DNA methodologies, this subclone fragment
and the pPTloxPneo plasmid (containing a loxP-Xanked neomycin resis-
tance cassette and pGK-tk cassette) were used to manufacture the knock-
out construct. The loxP-Xanked neomycin resistance cassette was
introduced into the second exon of Elovl4. The construct contains an
approximate 2.5 kb short arm and a 4 kb long arm for recombination
(Fig. 1). The construct was isolated by NotI digest and gel electrophoresis
prior to transfection.Fig. 1. Targeted mutagenesis of the Elovl4 gene. (A) The targeting vector used for disrupting the endogenous Elovl4 gene. A pGKneo cassette Xanked by
loxP (open triangles) was inserted into exon 2 of a 15 kb Elovl4 fragment. The disrupted Exon 2 construct is Xanked by 2.5 kb short arm (B) and 4 kb long
arm (A) sequences for homologous recombination in embryonic stem cells. Transcription directions of neo and tk are indicated by one way arrows. (B)
The endogenous gene. The direction of Elovl4 transcription is from left to right. (C) The Elovl4 locus after homologous recombination. Arrows indicate
primers used for PCR genotyping.
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struct) were injected into blastocysts harvested from C57BL/6 mice, fol-
lowed by the surgical transfer of the blastocysts to pseudopregnant foster
mothers. Germline transmission was determined by southern blot and
PCR of DNA extracted from tail biopsies. For PCR genotyping, one set of
primers were engineered to identify the introduced Neo cassette (Neo 5-
ATC GCC TTC TAT CGC CTT CTT GAC GAG TTC-3) (Fig. 1), and
the other primer set ampliWed undisrupted exon 2 of the endogenous
Elovl4 gene (GWTF 5-TGT AGC AGA CTG GCC GCT GAT-3,
GWTR 5-CTC TGA AGA TGA AAA GGT TAA GCA-3) (Fig. 1).
2.2. Generation of the YP2 polyclonal antibody
A well conserved (among mammals) hydrophilic sequence between
amino acids 101 (Ser) to 162 (His) in ELOVL4 was used to generate the
antibody. After expression in Escherichia coli (BL21), the peptide was
puriWed using a Ni-NTA spin column (Qiagen, CA). Rabbit polyclonal
antibodies were generated and antisera aYnity puriWed using antigen-con-
jugated columns (UltraLink Immobilization Kit, PIERCE). The poly-
clonal antibody was further puriWed using the method of Olmsted (1986).
BrieXy, the ELOVL4 peptide was separated on SDS–PAGE along with
pre-labeled protein standards, transferred onto Immobilon-P, and blocked
with 5% non-fat dry milk and 3% BSA in Tris-buVered saline (TBS). The
membrane was incubated with the rabbit anti-sera and the region of the
blot corresponding to the expected mobility of the ELOVL4-His tagged
protein was excised. The YP2 antibody was eluted from the membrane
strips in 0.2 M glycine-HCL, pH 2.5 and then dialyzed against PBS over-
night. The antibody was characterized using a combination of Western
blot and immunohistochemistry (IHC).
2.3. Histology and immunohistochemistry (IHC)
Eyes were dissected from adult Elovl4+/¡ and Elovl4+/+ mice and Wxed
in 4% paraformaldehyde/0.1 M PBS overnight at 4 °C. The eyes were then
cryoprotected in a graded series of sucrose/0.1 M PBS (10–30%). Eyes were
subsequently frozen in OCT compound and cryosectioned at 12 m in
thickness. For embryonic day 18 (E18) Elovl4 mice, heads were removed,
Wxed, and prepared for cryosectioning as above.
Sections were incubated in 10% normal goat serum (NGS) for 1 h, fol-
lowed by incubation with the YP2 antibody, at approximately 3 ng/ml,
overnight at 4 °C. The monoclonal anti-mouse rod cyclic nucleotide gated
channel alpha subunit (CNGCa1) (gift of Dr. Robert Molday), was
diluted 1:100 for use. The sections were incubated with a goat anti-rabbit
Texas Red or FITC- or goat anti-mouse FITC-conjugated secondary anti-
bodies (Vector Laboratories) for 1 h and coverslipped with Vectashield
(Vector Laboratories) containing propidium iodide (PI) to label cell
nuclei. Images were captured with a Zeiss LSM 510 confocal microscope.
2.4. Western blot
Fresh bovine eyes were obtained from a local slaughterhouse and
human donor retinal tissue from the Lion’s Eye Bank in Utah. Retinas
were homogenized in lysis buVer 0.05 M Tris–HCl (pH 7.4), 0.15 M NaCl,
0.001 M EDTA, 0.1% SDS, and 1% Triton X-100. Ten micrograms of each
protein lysate sample was run on 12% PAGE, transferred onto an Immo-
bilon-P Wlter, blocked in dry milk, and incubated with the YP2 antibody.
After washing, the Wlter was incubated in HRP-conjugated goat anti-rab-
bit secondary antibody and ELOVL4 protein was detected with an ECL
detection kit (Amersham).
2.5. RT-PCR
To determine if loss of the Elovl4 allele in Elovl4+/¡ mice may induces
compensatory upregulated expression by the remaining gene, we per-
formed RT-PCR to examine relative levels of Elovl4 RNA in these mice.
We generated Elovl4 primers in separate exons (exons 2 and 6), ensuring
intervening introns, for ampliWcation of reverse transcribed RNA withexpected amplicon size D 478 bp. Total RNA was extracted from Elovl4+/¡
and Elovl4+/¡ mouse retinas using conventional methods for Trizol
reagent. One hundred nanograms total RNA was reverse transcribed and
ampliWed using the Qiagen one-step PCR kit and Elovl4 speciWc primers
(forward, 5-ATG GTT TTG CTT AAC CT -3, and reverse, 5-TTG
GGG AAG GGG CAG TC-3). The GAPDH primer set (forward, 5-
AAA TGG TGA AGG TCG GTG TG-3, and reverse, 5-CAT GTA
GAC CAT GTA GTT GAG-3) was similarly used in parallel reactions
from each retinal RNA sample. Five microliter volumes were collected
from each reaction at 5 cycle intervals between 20 and 35 cycles of ampliW-
cation. At the completion of the PCR reaction, the aliquots were run on an
agarose gel and ethidium bromide stained bands were examined by densi-
tometry on an Eagle Eye II gel documentation system. Relative Elovl4
levels were normalized to GAPDH signals.
2.6. Electroretinograms
After overnight dark adaptation, mice were anesthetized with ketamine
(80 mg/kg) and xylazine (16 mg/kg), and the pupils dilated with 1% tropica-
mide and 2.5% phenylephrine HCl. Mice were placed on a heating pad. ERGs
were recorded with a gold wire loop, making contact with the corneal surface
through a layer of 1% methylcellulose. Needle electrodes placed in the cheek
and tail served as reference and ground leads, respectively. Responses were
ampliWed (2–10,000 Hz), averaged, and stored using a PC-based signal aver-
aging system with custom software. Flash stimuli were presented in a ganzfeld
bowl. Dark-adapted responses were obtained to strobe Xashes covering a 5-
log unit intensity range (log ¡2, ¡1, 0, +1, and +2 cds/m2). Cone-mediated
responses were obtained to stimuli superimposed on a steady rod-desensitiz-
ing adapting Weld (50–75 fL). The major ERG components were analyzed
conventionally. The amplitude of the dark-adapted ERG a-wave was mea-
sured from the baseline to the a-wave trough. The amplitude of the dark- and
light-adapted b-wave was measured from the trough of the a-wave to the b-
wave peak or, if no a-wave was present, from the baseline to the b-wave peak.
Implicit times reXect the time elapsed between stimulus presentation and the
a-wave trough or the b-wave peak. Adjusted a-wave ERGs were generated by
plotting amplitude responses (V) at 7 ms after Xash. This timepoint corre-
sponds to a more pure photoreceptor response, unmodiWed by the b-wave
which may aVect the trough a-wave amplitude.
2.7. Fatty acid analysis
Embryonic day 19 mice were used for FA analysis. Five hundred micro-
liters of blood were collected from each mouse and frozen at ¡80 °C. Red
blood cells were analyzed according to the method by Lagerstedt et al.
(2001) using capillary gas chromatography with electron-capture negative-
ion mass spectrometry (Agilent, Palo Alto, CA). Fatty acid-pentaXuoroben-
zyl esters were analyzed using an AT-Silar-100 capillary column (Alltech
Assoc. Inc, Nicholasville, KY). Each fatty acid was matched to a labeled
internal standard of closest chain length, retention time, and concentration.
Individual lipids are expressed as a percentage of the total lipid analyzed.
2.8. Statistics
Errors are expressed as standard errors of the mean (SE). Comparisons
between two diVerent groups for the Elovl4+/¡ and Elovl4+/+ ERGs and
embryonic weights were measured using the Student’s t-test. Lipid statisti-
cal analysis was done using SPSS’s independent sample’s t-test (SPSS Inc.,
Chicago, IL). The probability level at which the null hypothesis was
rejected was set at p < 0.05.
3. Results
3.1. Elovl4 knockout mice are perinatal lethal
Mouse embryonic stem cells containing the integrated
Elovl4 construct (Fig. 1) were injected into blastocysts
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transfer of the blastocysts to the uterine horns of pseudo-
pregnant foster mothers. We identiWed chimeric mice in
which the ES cells have contributed to the mouse by
visual inspection (these mice exhibited bicolored coats).
Germline transmission was determined by the presence of
agouti in the oVspring. We used the C57BL/6 strain for
backcross since they are well-characterized, tend to be
physically and reproductively robust, and are free of reti-
nal degeneration. Germline transmission was determined
from Southern blot and PCR analysis of DNA extracted
from tail biopsies. PCR based genotyping included prim-
ers which identify a sequence from the Neo cassette
(Fig. 2) and the undisrupted endogenous allele was identi-
Wed with a primer set corresponding to exon 2 of the
Elovl4 gene.Elovl4¡/¡ mice were born with an expected Mendelian
frequency, yet they died shortly after birth. Upon process-
ing of embryos for cryostat sectioning, we found that the
E18 Elovl4¡/¡ pups were consistently smaller than Elovl4+/¡
and Elovl4+/+ littermates (Fig. 2). We weighed 3 litters of
pups from E18 timepoints, and found that the Elovl4¡/¡
pups were 13.1% smaller (or 86.9% the size of the other
pups in the litters) on average (p < 0.001) than the Elovl4+/¡
or Elovl4+/+ pups (Fig. 2 and Table 1). The overall appear-
ance of Elovl4¡/¡ pups was essentially normal except for
shortened forelimbs and smaller body size relative to het-
erozygous and wildtype littermates.
We next examined Elovl4+/¡ mice for altered Elovl4
RNA levels relative to that of wildtype mice. Total RNA
was extracted from Elovl4+/¡ and Elovl4+/+ mouse retinas
and used for RT-PCR analysis. We found that Elovl4 RNAFig. 2. IdentiWcation and characterization of Elovl4 mice. (A) Genotypes determined by PCR ampliWcation of DNA extracted from tail biopsies. The
upper band is generated when the endogenous Elovl4 gene is present, and the lower band from the disrupted gene. The left lane shows Elovl4+/+ genotype,
the middle lane shows Elovl4+/¡, and the right lane represents Elovl4¡/¡ genotyping reactions. (B) Size comparison of embryonic day 18 Elovl4+/+, Elovl4+/
¡, and Elovl4¡/¡ littermates. (C) Mean weight diVerences are shown for Elovl4 knockout pups vs. wildtype and heterozygous pups. (D) RT-PCR results
show that Elovl4 RNA levels are reduced by 46% in Elovl4+/¡ mice relative to wildtype mice. GAPDH ampliWcation signals used for normalization
between retinal samples. N D 4.Table 1
Elovl4 embryonic day 18 group weight statistics
a Equal variances assumed.
b Equal variances not assumed.
Genotype N Mean SD SE
+/+ and +/¡ 11 1.0521 0.05299 0.01598
¡/¡ 4 0.8588 0.05255 0.02627
Independent samples test
Levene’s test for equality 
of variances
t-test for equality 
of means
95% ConWdence interval 
of the diVerence
F SigniWcance t df SigniWcance (2-tailed) Mean diVerence SE diVerence Lower Upper
0.008a 0.930 6.322 13 0.000 0.19522 0.03088 0.12851 0.26193
b 6.349 5.407 0.001 0.19522 0.03075 0.11793 0.27251
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Although protein levels were not directly examined, these
results suggest that there may be a reduction in Elovl4 lev-
els in the heterozygous mice.
3.2. ELOVL4 antibody characterization
The ELOVL4 fusion protein was expressed in E. coli and
puriWed using a Ni-NTA spin column prior to injection into
rabbits. Serum was collected and puriWed using the method
Fig. 3. Western blotting using the YP2 (ELOVL4) antibody. (A) YP2 rec-
ognizes the His-Elovl4 fusion protein expressed in bacterial lysates. (B)
Human and bovine retinal lysates showing ELOVL4 protein detection
with the YP2 antibody and eVective loss of signal with ELOVL4 protein
preabsorption.of Olmsted (1986). This antibody was characterized by
western blot and immunohistochemistry using lysates from
E. coli, bovine, human, and mouse retinal tissues (Fig. 3).
ELOVL4 bands on Western blots were eVectively elimi-
nated by preabsorption of the YP2 antibody with the pep-
tide prior to incubation with blots (Fig. 3).
ELOVL4 immunolabeling, using the YP2 antibody, was
obvious in human retinas within the inner segments (IS) of
both rod and cones, synaptic termini of the outer plexiform
layer (OPL), cells of the inner nuclear layer (INL), and the
ganglion cell layer (GCL) (Fig. 4A). This immunolabeling
proWle is similar to previously reported ELOVL4 staining
in human retinal tissue (Grayson & Molday, 2005). The
YP2 immunolabeling pattern in adult mouse retina was
similar to that in the human retina (Fig. 4A and B), and
staining within the retina was absent when antibody was
preabsorbed with the protein prior to IHC (Fig. 4C).
3.3. Histology and immunohistochemistry in embryonic and 
adult Elovl4 mice
Based on perinatal lethality, embryonic day 18 Elovl4¡/¡
mice were collected and compared, by histological and
immunocytochemical analyses, to Elovl4+/+ and Elovl4+/¡ lit-
termates, for alterations in retinal development. In both
Elovl4+/+ and Elovl4+/¡ E18 mice, immunolabeling was
apparent in the GCL, cells in the neuroblast layer, and the
developing photoreceptor IS region (Fig. 4D and E). The
proWle of Elovl4 immunolabeling within the embryonic
retina was similar to results from previous studies usingFig. 4. ELOVL4 immunolabeling in human and mouse retinal sections. ELOVL4 signal is green in all Wgures. (A) Normal 27 year old human retina show-
ing that the YP2 antibody immunolabels photoreceptor inner segments (IS) (short arrow-cone IS, long arrow-rod IS), outer plexiform layer (OPL), and
cells within the inner nuclear layer (INL) and ganglion cell layer (GCL). Cell nuclei are labeled with PI (red). (B) A similar immunolabeling proWle is evi-
dent in adult mouse retina. (C) Preabsorption control in mouse retina. (D–F) Embryonic day 18 retinas from Elovl4+/+ (D), Elovl4+/¡ (E), and Elovl4¡/¡
(F) mice immunostained with the YP2 antibody. (For interpretation of the references to color in this Wgure legend, the reader is referred to the web version
of this paper.)
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nas (Zhang et al., 2003). KO embryos showed no Elovl4
immunoreactivity (Fig. 4F) using the YP2 antibody. At E18,
knockout mice showed no diVerence in ongoing organization
and approximately equivalent cell numbers measured by PI
nuclear staining within the retinal layers (data not shown).
Elovl4+/¡ mice showed relatively normal retinal develop-
ment, adult architecture, and Elovl4 immunolabeling rela-
tive to wildtype mice (Fig. 5). Often, the outer segments of
11 month old Elovl4+/¡ mice appeared somewhat less orga-
nized and slightly shorter than age-matched wildtype mice
(Fig. 5B). However, at this age the ONL layer thickness was
equivalent to age-matched normal mice.
3.4. ERG analysis
We examined the mice for altered retinal function using
ERG at 9 months of age. Elovl4+/¡ mice showed a tendency
for enhanced mesopic ERG responses relative to age-
matched wildtype mice between log 0 cds/m2 and log +1
cds/m2 Xash intensities (Fig. 6). Statistically signiWcant
diVerences were found in dark adapted mice at a stimulus
intensity of log 0 cds/m2 for the scotopic a-wave (Fig. 6 and
Table 2). When we adjusted the scotopic a-wave to show
photoreceptor responses at 7 ms after the light pulse, the
Elovl4+/¡ mice continued to exhibit signiWcantly increased
values within the log 0 to +1 cds/m2 range. Scotopic b-wave
responses, while not statistically signiWcant, also showed a
tendency in this range towards ampliWed responses. Elovl4+/
¡ mice also showed an enhanced photopic b-wave which
was statistically signiWcant at log 0 cds/m2. These data sug-
gest that Elovl4+/¡ mice show slightly altered ERG
responses within a deWned region of light intensities.
3.5. FA levels in red blood cells (RBCs)
ELOVL4 is proposed to play a role in long-chain fatty acid
elongation. Since the amount of tissue in the embryonicmouse retina is insuYcient for these studies, we compared the
RBC membrane fatty acid proWles between normal, Elovl4+/¡,
and Elovl4¡/¡ mice. RBC membrane fatty acid content has
been previously used as a marker for systemic and retina fatty
acid levels (HoVman & Birch, 1995). Elovl4¡/¡ mice showed
an increase in poly-unsaturated fatty acids (PUFAs) com-
pared to normal controls (Fig. 7). The increase in docosahexa-
enoic acid (DHA) the end product of omega-3 PUFA
synthesis, was of particular interest since DHA has been
shown to be essential for normal retinal development (Ander-
son, Connor, & Corliss, 1990; Bazan, 1989). However, the pre-
cursor to DHA, eicosapentaenoic acid (EPA), was
signiWcantly decreased in the RBC lipid membranes of the
Elovl4¡/¡ mice (Fig. 7). Elovl4+/¡ mice exhibited intermediate
but generally not signiWcantly diVerent levels in PUFA classes
(Fig. 7) relative to Elovl4¡/¡ and control mice.
4. Discussion
Stargardt macular dystrophy 3 (STGD3), an autosomal
dominant juvenile retinal degeneration, is induced by muta-
tion of one copy of the ELOVL4 gene. Current evidence sug-
gests that the mutant 5bp ELOVL4 deletion exerts a
dominant negative eVect over that of the remaining wildtype
allele. It is not currently clear whether the mutant ELOVL4
protein induces retinal degeneration in human patients
through an unidentiWed “gain of function” activity or through
elimination of wildtype protein activity due to loss of ER
localization and function. In previous cell culture studies, sev-
eral independent laboratories reported that all disease-causing
ELOVL4 mutations, identiWed to date, bind and sequester the
wildtype protein in nonER localized aggregates. This would,
in eVect, cause a functional loss of normal ELOVL4 activity.
In addition, misfolding of the mutant protein could induce the
ER uncoupled protein response thereby impacting cell viabil-
ity. Karan et al. recently showed upregulation of UPR pro-
teins and induction of apoptosis in HEK293 cells transfected
with ELOVL4 mutants (Karan, Lillo, et al., 2005).Fig. 5. Retinal sections from Elovl4+/+ (A) and Elovl4+/¡ (B) 11 month old mice. Nuclei are stained with PI and outer segments are labeled with a CNGCa1
antibody (green). Retinal layers are normal in the Elovl4+/¡ retina. Arrows indicate some disorganization in the outer segments. (For interpretation of the
references to color in this Wgure legend, the reader is referred to the web version of this paper.)
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ERG amplitude diVerences between Elovl4+/¡ and Elovl4+/+ mice at 9
months of age
Italicised values show t-test signiWcance at p6 0.05.
Intensity (log cds/m2) Elovl4+/¡:Elovl4+/+
¡2 ¡1 0 1 2
Scotopic A 0.21 0.19 0.03 0.16 0.27
Adjusted scotopic A 0.22 0.22 0.05 0.19 0.49
Scotopic B 0.50 0.22 0.09 0.26 0.37
Photopic B 0.15 0.02 0.24 0.50We previously generated transgenic mice expressing the
human ELOVL4 5bp deletion mutant. Based on expression
level of the transgenes, the mouse lines generated in the pre-
vious study exhibited varying rates of retinal degeneration
in the presence of the endogenous murine Elovl4 genes.
While these mice veriWed the eVect of the human ELOVL4
mutation, it was not possible to examine the consequences
of loss of a functional Elovl4 gene vs. the role of ELOVL4
mutants on retinal pathogenesis. In this study, we generated
mice incorporating a targeted deletion of the Elovl4 coding
region to examine the impact of Elovl4 loss on retinal
status.Fig. 6. Nine month old Elovl4+/+ and Elovl4+/¡ mice scotopic and photopic single Xash ERG responses. The scotopic a and b waves were measured at
intensities log ¡2, ¡1, 0, +1, and +2 cds/m2. The Wlled symbols show trough a wave amplitude values (V), and the open symbols represent the (adjusted)
a wave values at 7 ms after light Xash. The dark line with squares represent the mean Elovl4+/+ amplitude responses in V (N D 5) and the dashed line with
diamonds represent the mean Elovl4+/¡ (heterozygous) mouse responses (N D 11). Note that in both sets of scotopic A wave plotted values the heterozy-
gous mice show a tendency for enhanced responses at mesopic intensities. The scotopic B wave shows a similar enhanced response, although not signiW-
cant at log 0 cds/m2. The Elovl4+/¡ mice also show signiWcantly enhanced photopic B wave amplitude at log 0 cds/m2. Representative scotopic and photopic
ERG traces (at intensity D log 0 cds/m2) are shown in the lower right corner.
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(knockout) mice supports an essential requirement for
Elovl4 in normal development. While exhibiting slight
structural abnormalities in forelimb development, the over-
all retinal architecture at embryonic day 18 appeared rela-
tively normal. Based on previously reported Elovl4
expression in the brain, it is possible that abnormal devel-
opment of the CNS may account for the lethality of these
mice. Preliminary studies, however, have so far not shown
any obvious histological abnormalities in the brain.
In this study, we show that Elovl4+/¡ mice, although exhib-
iting reduced wildtype Elovl4 RNA levels, exhibit relatively
normal photoreceptor development and no apparent photo-
receptor degeneration up to 11 months of age. We show that
Elovl4 heterozygosity is not suYcient to induce an early onset
photoreceptor degeneration and, therefore, haploinsuY-
ciency is likely not the mechanism governing retinal degenera-
tion in Stargardt patients. However, the Elovl4+/¡ mice
exhibited a small but signiWcant enhancement of scotopic and
photopic ERGs, suggesting that wildtype levels of Elovl4 may
be required for normal ERG responses. This eVect on ERG
responses was particularly signiWcant with log 0 cds/m2 Xash
intensities. While reduction in Elovl4 is not suYcient to
induce retinal degeneration, the results from these studies sug-
gest an unidentiWed eVect on retinal physiology.
Increased DHA levels in the RBCs in Elovl4¡/¡ mice is a
surprising result since it is the end product of omega-3 lipid
biosynthesis and has been a candidate substrate or product
for Elovl4 function in retina and brain. Other signiWcant
PUFA pathways such as the omega-6 pathway also showed
increases in C22 unsaturated lipids similar to DHA. Based
on the general increase in C22 lipids it would appear that
Elovl4 activity impacts, directly or indirectly, this step of
FA synthesis.Loss of Elovl4 results in embryonic lethality and disrup-
tion of one gene does not result in compensatory upregula-
tion of RNA levels by the remaining functional gene.
Assuming protein levels are reduced and, coupled with the
diVerences in ERGs described in this study, suggest that
development or maintenance of retinal function may be
aVected in Elovl4+/¡ mice. Elovl4 knockout mice are cur-
rently being examined for cause of lethality. These studies
should provide important new information concerning the
role of ELOVL4 in development and broaden our under-
standing of ELOVL4 function.
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